Overview

Additional Insulin for Fat and Protein in Children With Diabetes Study

Status:
Terminated
Trial end date:
2018-08-31
Target enrollment:
0
Participant gender:
All
Summary
The aims of the study are to see if additional insulin doses for the fat and protein in a meal, given at different times, improve blood glucose levels and are safe and acceptable to children with Type 1 diabetes using multiple daily insulin injections.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Oxford University Hospitals NHS Trust
Treatments:
Insulin
Insulin Aspart
Insulin, Globin Zinc
Criteria
Inclusion Criteria:

- Diagnosis of Type 1 diabetes (for at least a year)

- On multiple daily insulin injections, including basal long-acting insulin and
rapid-acting insulin before each meal.

- HbA1c < 75 mmol/mol (9.0%)

- Participant and/or parent/legal guardian willing and able to give informed consent for
participation in the study.

- Family have a freezer in which to safely store the test meals.

- In the Investigator's opinion, is able and willing to comply with all trial
requirements.

Exclusion Criteria:

- HbA1c greater than 75 mmol/mol (9.0%)

- Child unwilling to agree to second insulin injection at a meal-time

- Untreated coeliac disease or other concomitant condition likely to affect BG control

- Food allergies (other than controlled Coeliac Disease)

- Vegetarians, vegans or patients with religious dietary restrictions (as the standard
meal contains meat)

- Participant taking any glucose-containing medication concurrently